ArticleThe oncologist2025

Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors.

Zhen-Xin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.